Neuronetics, Inc. (STIM) Stock Score, Valuation & Financial Research
Neuronetics, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 14/100.
Quick answer for STIM
Neuronetics, Inc. currently has a Wall Street Score of 14/100. The stored market price is $3.03. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Neuronetics, Inc. does
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2
STIM financial snapshot
- Wall Street Score:
- 14/100
- Current price:
- $3.03
- Market capitalization:
- $210.9M
- Revenue:
- $151.6M
- Net income:
- $-37.1M
- Free cash flow:
- $-21.2M
- Cash:
- $13.2M
- Total debt:
- $85.4M
- EPS:
- -0.59
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 33/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $-21.2M, showing cash burn in the current stored period.
- The balance sheet shows $13.2M of cash versus $85.4M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research STIM
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.